Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Gross Profit: 2020-2025

Historic Gross Profit for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $179.8 million.

  • Harmony Biosciences Holdings' Gross Profit rose 25.51% to $179.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $641.7 million, marking a year-over-year increase of 19.66%. This contributed to the annual value of $557.9 million for FY2024, which is 21.08% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Gross Profit stood at $179.8 million, which was up 10.76% from $162.3 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Gross Profit peaked at $179.8 million during Q3 2025, and registered a low of $49.3 million during Q1 2021.
  • Its 3-year average for Gross Profit is $137.6 million, with a median of $140.7 million in 2024.
  • Data for Harmony Biosciences Holdings' Gross Profit shows a peak YoY skyrocketed of 201.02% (in 2021) over the last 5 years.
  • Harmony Biosciences Holdings' Gross Profit (Quarterly) stood at $73.4 million in 2021, then surged by 38.19% to $101.4 million in 2022, then increased by 23.50% to $125.3 million in 2023, then grew by 17.24% to $146.9 million in 2024, then increased by 25.51% to $179.8 million in 2025.
  • Its Gross Profit was $179.8 million in Q3 2025, compared to $162.3 million in Q2 2025 and $152.7 million in Q1 2025.